NCT07077473 Observing the Efficacy and Safety of Different Drugs Used in Real-world Familial Mediterranean Fever (FMF) Cases
| NCT ID | NCT07077473 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Tongji Hospital |
| Condition | Familial Mediterranean Fever (FMF ) |
| Study Type | OBSERVATIONAL |
| Enrollment | 12 participants |
| Start Date | 2018-01-01 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 12 participants in total. It began in 2018-01-01 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
retrospective observe the efficacy and safety of different drugs used in familial Mediterranean fever (FMF) cases in real-world
Eligibility Criteria
Inclusion Criteria: \- Clinical diagnosis of Familial Mediterranean fever (FMF) patients (Tel Hashomer criteria) Exclusion Criteria: * Have a history of mental illness, or alcohol and drug dependence； * Pregnant, with severe infection, severe cardiac insufficiency, severe liver or kidney dysfunction； * Complicated with tumors, organ transplants, etc. which have significant impact on the immune system or require the use of immunosuppressants.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07077473 clinical trial?
This trial is open to participants of all sexes, studying Familial Mediterranean Fever (FMF ). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07077473 currently recruiting?
Yes, NCT07077473 is actively recruiting participants. Contact the research team at yuyikai@163.com for enrollment information.
Where is the NCT07077473 trial being conducted?
This trial is being conducted at Wuhan, China.
Who is sponsoring the NCT07077473 clinical trial?
NCT07077473 is sponsored by Tongji Hospital. The trial plans to enroll 12 participants.